Difference between revisions of "Hypoxia inducible factor 1"
m |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| align="center" colspan="2" bgcolor="#ffffff" | | | align="center" colspan="2" bgcolor="#ffffff" | | ||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | Hypoxia inducible factor 1 beta | + | | Hypoxia-inducible factor 1-beta |
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | | + | | Aryl hydrocarbon receptor nuclear translocator |
| + | Dioxin receptor, nuclear translocator | ||
|- | |- | ||
| Determination type | | Determination type | ||
| − | | | + | | in situ/in vitro |
|- | |- | ||
| Source | | Source | ||
| − | | | + | | Homo sapiens |
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
| Line 20: | Line 21: | ||
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
| − | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P27540 P27540] |
|- | |- | ||
| Interacting residues | | Interacting residues | ||
| − | | | + | | Not determined yet |
|- | |- | ||
| Interacting sequence | | Interacting sequence | ||
| − | | | + | | Not determined yet |
| + | |- | ||
| + | | TG2 Swissprot ID | ||
| + | | [http://au.expasy.org/uniprot/P21980 P21980] | ||
| + | |- | ||
| + | | Interacting residues of TG2 | ||
| + | | Not determined yet | ||
| + | |- | ||
| + | | Interacting sequence of TG2 | ||
| + | | Not determined yet | ||
|- | |- | ||
| Structure | | Structure | ||
| − | | [http://www.rcsb.org/pdb/explore/explore.do?structureId= | + | | [http://www.rcsb.org/pdb/explore/explore.do?structureId=4EQ1 4EQ1] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | - |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| − | | [http://iupred.enzim.hu | + | | [http://iupred.enzim.hu IUPred] |
|- | |- | ||
| Reference | | Reference | ||
| Line 47: | Line 57: | ||
to its DNA response element. | to its DNA response element. | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase interaction partners|*]] | [[Category:Tissue transglutaminase interaction partners|*]] | ||
Latest revision as of 12:25, 21 March 2017
| Hypoxia inducible factor 1 | |
|---|---|
| Substrate peptide name | Hypoxia-inducible factor 1-beta |
| Synonyms | Aryl hydrocarbon receptor nuclear translocator
Dioxin receptor, nuclear translocator |
| Determination type | in situ/in vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol/Nucleus |
| Swissprot ID | P27540 |
| Interacting residues | Not determined yet |
| Interacting sequence | Not determined yet |
| TG2 Swissprot ID | P21980 |
| Interacting residues of TG2 | Not determined yet |
| Interacting sequence of TG2 | Not determined yet |
| Structure | 4EQ1 |
| Surface accessibility | - |
| Disorder prediction | IUPred |
| Reference | PMID:18375543 |
| Notes | TG2 inhibited a HIF-dependent transcription under hypoxic conditions without affecting nuclear protein levels
for HIF1{alpha} or HIF1{beta}, their ability to form the HIF1 heterodimeric transcription factor, or HIF1 binding to its DNA response element. |
